期刊文献+

心血管内科中卡维地洛的应用效果 被引量:2

Application effect of carvedilol in cardiovascular medicine
下载PDF
导出
摘要 目的对卡维地洛在心血管内科中的应用效果予以分析和探讨。方法将2014年1月至2015年12月期间于我院进行治疗的心血管疾病患者120例随机均分为两组,分别为观察组和对照组。观察组采用卡维地洛进行治疗,对照组采用常规的治疗方法进行治疗。对两组患者的治疗效果、治疗有效率和不良反应发生率进行比较。结果观察组的治疗效果明显优于对照组,观察组的治疗有效率明显高于对照组,且P<0.05,差异具有统计学意义。观察组的不良反应发生率明显低于对照组,且P<0.05,差异具有统计学意义。结论卡维地洛在心血管疾病的治疗当中适用性比较广泛,包括高血压、心力衰竭、扩张性心肌病等,经过长期的综合治疗效果显著,治疗的有效率高,不良反应的发生率低,值得我们在临床上进一步的推广和使用。 Objective To investigate the application effect of carvedilol in cardiovascular medicine.Methods A total of 120 patients with cardiovascular diseases who were treated in our hospital from January 2014 to December 2015 were enrolled and randomly divided into observation group and control group. The patients in the observation group were given carvedilol, and those in the control group were given routine treatment. The clinical outcome, response rate, and incidence of adverse events were compared between the two groups. Results The observation group showed a significantly better clinical outcome, a significantly higher response rate, and a significantly lower incidence rate of adverse events compared with the control group(all P〈0.05). Conclusion Carvedilol is widely used in the treatment of cardiovascular diseases, including hypertension, heart failure, and dilated cardiomyopathy, and long-term multimodality therapy can achieve a significant effect, with a high response rate and a low incidence of adverse events. Therefore, carvedilol holds promise for clinical application.
作者 林森洋
出处 《心血管病防治知识(学术版)》 2016年第7期91-93,共3页 Prevention and Treatment of Cardiovascular Disease
关键词 心血管内科 卡维地洛 应用效果 Carotid stenosis Ischemic cerebrovascular disease Diagnosis Treatment
  • 相关文献

参考文献6

二级参考文献17

  • 1王文丰,杨庭树.卡维地洛在心力衰竭治疗中的应用[J].中国临床药理学杂志,2004,20(4):309-311. 被引量:9
  • 2Mc Tavish D,Campoi-Richards D,Sorkin EM.Carvedilol: a review of its pharrnacodynamic and pharmacokinetic properties and therapeutic efficacy[J].Drugs,1993,45(2): 232-238.
  • 3Ruffolo RR Jr, Feuerstein GZ.Pharmacology of Carvedilol: rationale f or use in hypertension, coronary artery disease,and congestive heart failure[J].Cardiovasc Drugs Ther,1997, ll(suppl 1): 247-256.
  • 4Sponer G,Kaski JC,Langdon CG,et al.Pharmacological profile of carvedi lol as a B -blocking agent with Vasdilating and hypotensive properties[J].J Cardiovasc Pharmacol,1987,9(3): 317.
  • 5蒋玉立.卡维地洛在心血管疾病治疗中的地位[J].中国冶金工业医学杂志,2013(8):142-144.
  • 6范红星.卡维地洛在心血管内科应用的临床评价[J].中国转化医学和整合医学研讨会论,2015(1):37-42.
  • 7Li G,Liu WY,Yan PS,Hao SF.Significance of type I and III precollagen mRNA in rheumatic myocardium[J].DiSi Junyi Daxue Xuebao(J Fourth Mil Med Univ),2010,21(5):550-553.
  • 8徐为民.卡维地洛治疗慢性心力衰竭临床分析[D].吉林大学2005
  • 9齐丽伟.卡维地洛治疗慢性心力衰竭的临床研究[D].山西医科大学2003
  • 10郑海曙.卡维地洛对扩张性心肌病心衰疗效观察[J].慢性病学杂志,2010,12(5):408-409. 被引量:2

共引文献10

同被引文献2

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部